Taranabant is a weight-loss medication that was approved by the U.S. Food and Drug Administration (FDA) in 2007. It is used as an adjunct to diet and exercise for obese patients with a body mass index of 30 and above, or those who are overweight with a body mass index of 27 or above and have at least one weight-related condition such as high blood pressure or diabetes. Taranabant works by blocking the action of an enzyme in the body called cannabinoid receptor type 1 (CB1), which is responsible for regulating energy balance and metabolism. By blocking this receptor, Taranabant helps to reduce the amount of fat stored in the body and increases the body’s metabolism. Taranabant is usually taken once daily with a meal or snack. Common side effects include nausea, vomiting, constipation, dizziness, and headache.
Taranabant was a drug candidate under investigation for obesity management, but its development was discontinued. Here's what you should know about it:
Type of Drug:
- Taranabant belonged to a class of drugs called cannabinoid receptor type 1 (CB1) inverse agonists.
Intended Use:
- It was specifically targeted at the CB1 receptor, which plays a role in appetite regulation. By blocking this receptor, Taranabant aimed to reduce appetite and promote weight loss.
Development Status:
- Although Taranabant showed promise in initial studies, its development was halted due to safety concerns. Clinical trials revealed an increased risk of psychiatric side effects, such as depression and anxiety, in some patients.
How it Worked:
- As a CB1 inverse agonist, Taranabant essentially blocked the natural activity of the CB1 receptor. This receptor is involved in the body's endocannabinoid system, which influences appetite, mood, and other functions.
- By blocking the CB1 receptor, Taranabant aimed to suppress appetite and reduce cravings.
Reasons for Discontinuation:
- The potential benefits of weight loss were outweighed by the risk of serious psychiatric side effects.
- Researchers are still exploring safer and more effective ways to target the endocannabinoid system for weight management.
Current Alternatives:
- Currently, there are no medications specifically approved for weight loss that work through the same mechanism as Taranabant.
- Several other prescription medications and lifestyle changes are used for weight management, but their effectiveness can vary depending on the individual.